Honeywell International enters the July 23 earnings week with a notable reversal in both short positioning and options sentiment — a marked shift from the cautious setup described just days ago.
The most striking development since last week's note is how quickly the short rebuild has unwound. Short interest collapsed 41% over the past week, dropping from roughly 19 million shares back to 11.4 million — almost exactly where it was in late May. That erases the entire two-week buildup that had pushed SI to ~3% of the float. It now rests at 1.8% of the free float, a level too low to generate meaningful squeeze dynamics. The borrow market remains extremely loose: availability has eased back to over 2,300% of outstanding short interest, with borrowing costs still minimal at 0.50%. Nothing in the lending market suggests any unusual demand for the stock on the short side.
Options have flipped in the opposite direction — and just as sharply. The put/call ratio crashed to 0.34 on July 14, almost a full standard deviation below its 20-day average of 0.50. That's a dramatic reversal from the 0.72–0.88 range seen just days earlier, when the PCR was testing its 52-week high. The swing from near-maximum defensiveness to near-minimum hedging in a single session is striking, particularly with earnings eight days out. Either large holders unwound their hedges into the July 10 spike — when the PCR hit its 52-week high of 0.88 — or fresh call exposure was added Monday as the stock steadied. The short score tells a consistent story: it fell from 49.6 on July 6 to 38.5 now, a sharp drop that reflects the rapid exit of short positioning.
The Street remains broadly constructive, though target prices have been drifting lower. Morgan Stanley maintained its Equal-Weight rating on July 14 but cut its target from $490 to $245 — a move that looks like a post-spin adjustment rather than a change of view, as the prior $490 target clearly reflected a pre-separation share structure. Evercore ISI, on the other hand, raised its Outperform target from $265 to $275 on July 13, and JP Morgan trimmed slightly to $250 while keeping its Overweight rating. The consensus target of $246 sits roughly 10% above the current $222.68 close, implying modest upside that the Street still broadly endorses. Factor scores add a nuanced layer: HON ranks near the top of the universe on dividend quality (95th percentile) and scores well on forward earnings growth (86th percentile on 12-month EPS increases), but momentum and EPS surprise metrics are both weak, in the low-to-mid 20s. Bulls point to the aerospace spin-off as a re-rating catalyst. Bears flag cyclical exposure and the execution risk that always accompanies a major portfolio separation.
The earnings history is quietly constructive. Over the past four prints, HON moved +7.0%, +0.8%, +3.5%, and -3.1% on the day — three positive reactions and an average five-day follow-through of roughly +5% on the positive prints. That's not a stock with a pattern of blowing up on results. The one exception was the April 23 print, which produced a modest single-day decline and a slight negative five-day drift. Peer MMM slipped 0.9% on the week while HON fell 1.1%, suggesting the slight drag is in line with the broader industrials sector rather than company-specific.
What to watch on July 23 is whether management provides updated guidance around the aerospace spin-off timeline and how the automation and building-solutions segments are tracking against the three-year financial targets — the tension between a constructive long-term narrative and near-term cyclical headwinds is where the print will likely be judged.
See the live data behind this article on ORTEX.
Open HON on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
